Mechanism of apoptosis induction associated with ERK1/2 upregulation via goniothalamin in melanoma cells

Tangchirakhaphan,Suphakorn; Innajak,Sukanda; Nilwarangkoon,Sirinun; Tanjapatkul,Nudjaree; Mahabusrakum,Wilawan; Watanapokasin,Ramida

doi:10.3892/etm.2018.5762

Mechanism of apoptosis induction associated with ERK1/2 upregulation via goniothalamin in melanoma cells

Authors:
- Suphakorn Tangchirakhaphan
- Sukanda Innajak
- Sirinun Nilwarangkoon
- Nudjaree Tanjapatkul
- Wilawan Mahabusrakum
- Ramida Watanapokasin
View Affiliations

Affiliations: Skin Center, Faculty of Medicine, Srinakharinwirot University, Bangkok 10110, Thailand, Department of Biochemistry, Faculty of Medicine, Srinakharinwirot University, Bangkok 10110, Thailand, Department of Chemistry, Faculty of Science, Prince of Songkla University, Hat Yai, Songkhla 90112, Thailand
Published online on: January 17, 2018 https://doi.org/10.3892/etm.2018.5762
Pages: 3052-3058

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the effect of goniothalamin on apoptosis induction in the A375 melanoma cell line. Melanoma is a type of skin cancer with increased prevalence and no potential standard treatment. Goniothalamin is a plant, bioactive styrly‑lactone, which has various bioactivities including anti‑microbial, anti‑inflammatory and anti‑cancer. Apoptosis induction by goniothalamin has been studied in numerous cancer cell lines, however not in the melanoma cell line A375. The results of the MTT assay demonstrated that goniothalamin induced anti‑proliferation in a dose dependent manner. Hoechst staining assay demonstrated that goniothalamin induced chromatin condensation and apoptotic bodies in A375 treated cells, and JC‑1 staining revealed that goniothalamin induced mitochondrial membrane dysfunction in A375 cells. In addition, goniothalamin decreased the level of anti‑apoptotic proteins myeloid cell leukemia 1, B cell lymphoma (Bcl)‑2 and Bcl‑extra large, whereas it increased the level of pro‑apoptotic proteins, Bcl‑2 Associated X, apoptosis regulator, t‑BID and Bim in A375 treated cells. In addition, goniothalamin also increased active caspase‑9, ‑7 and cleaved‑poly (ADP‑ribose) polymerase expression in A375 treated cells. Furthermore, phosphorylated (p)‑pyruvate dehydrogenase kinase (PDK) 1 (Ser241) and p‑RAC‑alpha serine/threonine‑protein kinase (Akt; Ser473) were decreased, however c‑Jun and p‑extracellular signal‑regulated kinase (ERK)1/2 were increased upon goniothalamin treatment. These results suggest that goniothalamin has an effect, as anti‑proliferation and apoptosis induction in A375 cells were associated with upregulated p‑ERK1/2, c‑Jun and downregulated p‑PDK1 (Ser241), p‑Akt (Ser473) in A375 cells. Therefore, goniothalamin may be a potential candidate for anti‑cancer drug development for melanoma treatment.

View Figures

View References

1	Lopez AD, Mathers CD, Ezzati M, Jamison DT and Murray CJ: Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data. Lancet. 367:1747–1757. 2006. View Article : Google Scholar : PubMed/NCBI
2	Armstrong BK and Kricker A: The epidemiology of UV induced skin cancer. J Photochem Photobiol B. 63:8–18. 2001. View Article : Google Scholar : PubMed/NCBI
3	Diepgen TL and Mahler V: The epidemiology of skin cancer. Br J Dermatol. 146 Suppl 61:S1–S6. 2002. View Article : Google Scholar
4	Strickland PT, Vitasa BC, West SK, Rosenthal FS, Emmett EA and Taylor HR: Quantitative carcinogenesis in man: Solar ultraviolet B dose dependence of skin cancer in Maryland watermen. J Natl Cancer Inst. 81:1910–1913. 1989. View Article : Google Scholar : PubMed/NCBI
5	Mukherjee AK, Basu S, Sarkar N and Ghosh AC: Advances in cancer therapy with plant based natural products. Curr Med Chem. 8:1467–1486. 2001. View Article : Google Scholar : PubMed/NCBI
6	Ellis RE, Yuan JY and Horvitz HR: Mechanisms and functions of cell death. Annu Rev Cell Biol. 7:663–698. 1991. View Article : Google Scholar : PubMed/NCBI
7	Wiederschain G: Essentials of apoptosis. A guide for basic and clinical research. Springer; New York, NY: 2005
8	Klein G: Cancer, apoptosis, and nonimmune surveillance. Cell Death Differ. 11:13–17. 2004. View Article : Google Scholar : PubMed/NCBI
9	Kerr JF, Wyllie AH and Currie AR: Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 26:239–257. 1972. View Article : Google Scholar : PubMed/NCBI
10	Sun T, Miao X, Zhang X, Tan W, Xiong P and Lin D: Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma. J Natl Cancer Inst. 96:1030–1036. 2004. View Article : Google Scholar : PubMed/NCBI
11	Mosaddik MA and Haque ME: Cytotoxicity and antimicrobial activity of goniothalamin isolated from Bryonopsis laciniosa. Phytother Res. 17:1155–1157. 2003. View Article : Google Scholar : PubMed/NCBI
12	Chiu CC, Liu PL, Huang KJ, Wang HM, Chang KF, Chou CK, Chang FR, Chong IW, Fang K, Chen JS, et al: Goniothalamin inhibits growth of human lung cancer cells through DNA damage, apoptosis, and reduced migration ability. J Agric Food Chem. 59:4288–4293. 2011. View Article : Google Scholar : PubMed/NCBI
13	Innajak S, Mahabusrakum W and Watanapokasin R: Goniothalamin induces apoptosis associated with autophagy activation through MAPK signaling in SK-BR-3 cells. Oncol Rep. 35:2851–2858. 2016. View Article : Google Scholar : PubMed/NCBI
14	Portugal J and Waring MJ: Assignment of DNA binding sites for 4′,6-diamidine-2-phenylindole and bisbenzimide (Hoechst 33258). A comparative footprinting study. Biochim Biophys Acta. 949:158–168. 1988. View Article : Google Scholar : PubMed/NCBI
15	Lecoeur H: Nuclear apoptosis detection by flow cytometry: Influence of endogenous endonucleases. Exp Cell Res. 277:1–14. 2002. View Article : Google Scholar : PubMed/NCBI
16	Pihie A, Stanslas J and Din LB: Non-steroid receptor-mediated antiproliferative activity of styrylpyrone derivative in human breast cancer cell lines. Anticancer Res. 18:1739–1743. 1998.PubMed/NCBI
17	Al-Qubaisi M, Rosli R, Subramani T, Omar AR, Yeap SK, Ali AM and Alitheen NB: Goniothalamin selectively induces apoptosis on human hepatoblastoma cells through caspase-3 activation. Nat Prod Res. 27:2216–2218. 2013. View Article : Google Scholar : PubMed/NCBI
18	Wiart C: Goniothalamus species: A source of drugs for the treatment of cancers and bacterial infections? Evid Based Complement Alternat Med. 4:299–311. 2007. View Article : Google Scholar : PubMed/NCBI
19	Petsophonsakul P, Pompimon W and Banjerdpongchai R: Apoptosis induction in human leukemic promyelocytic HL-60 and monocytic U937 cell lines by goniothalamin. Asian Pac J Cancer Prev. 14:2885–2889. 2013. View Article : Google Scholar : PubMed/NCBI
20	Inayat-Hussain S, Annuar BO, Din LB, Ali AM and Ross D: Loss of mitochondrial transmembrane potential and caspase-9 activation during apoptosis induced by the novel styryl-lactone goniothalamin in HL-60 leukemia cells. Toxicol In Vitro. 17:433–439. 2003. View Article : Google Scholar : PubMed/NCBI
21	De Fátima A, Modolo LV, Conegero LS, Pilli RA, Ferreira CV, Kohn LK and De Carvalho JE: Styryl lactones and their derivatives: Biological activities, mechanisms of action and potential leads for drug design. Curr Med Chem. 13:3371–3384. 2006. View Article : Google Scholar : PubMed/NCBI
22	Vendramini-Costa DB, Alcaide A, Pelizzaro-Rocha KJ, Talero E, Ávila-Román J, Garcia-Mauriño S, Pilli RA, de Carvalho JE and Motilva V: Goniothalamin prevents the development of chemically induced and spontaneous colitis in rodents and induces apoptosis in the HT-29 human colon tumor cell line. Toxicol Appl Pharmacol. 300:1–12. 2016. View Article : Google Scholar : PubMed/NCBI
23	Sophonnithiprasert T, Nilwarangkoon S, Nakamura Y and Watanapokasin R: Goniothalamin enhances TRAIL-induced apoptosis in colorectal cancer cells through DR5 upregulation and cFLIP downregulation. Int J Oncol. 47:2188–2196. 2015. View Article : Google Scholar : PubMed/NCBI
24	Alabsi AM, Ali R, Ali AM, Al-Dubai SA, Harun H, Abu Kasim NH and Alsalahi A: Apoptosis induction, cell cycle arrest and in vitro anticancer activity of gonothalamin in a cancer cell lines. Asian Pac J Cancer Prev. 13:5131–5136. 2012. View Article : Google Scholar : PubMed/NCBI
25	Chen WY, Wu CC, Lan YH, Chang FR, Teng CM and Wu YC: Goniothalamin induces cell cycle-specific apoptosis by modulating the redox status in MDA-MB-231 cells. Eur J Pharmacol. 522:20–29. 2005. View Article : Google Scholar : PubMed/NCBI
26	Sophonnithiprasert T, Mahabusarakam W, Nakamura Y and Watanapokasin R: Goniothalamin induces mitochondria-mediated apoptosis associated with endoplasmic reticulum stress-induced activation of JNK in HeLa cells. Oncol Lett. 13:119–128. 2017. View Article : Google Scholar : PubMed/NCBI
27	Sophonnithiprasert T, Mahabusarakam W, Nakamura Y and Watanapokasin R: Antiproliferation and apoptosis induction in colorectal cancer cells by goniothalamin. J Med Assoc Thai. 98 Suppl 9:S146–S151. 2015.PubMed/NCBI
28	Tan BJ and Chiu GN: Role of oxidative stress, endoplasmic reticulum stress and ERK activation in triptolide-induced apoptosis. Int J Oncol. 42:1605–1612. 2013. View Article : Google Scholar : PubMed/NCBI
29	Guon TE and Chung HS: Moringa oleifera fruit induce apoptosis via reactive oxygen species-dependent activation of mitogen-activated protein kinases in human melanoma A2058 cells. Oncol Lett. 14:1703–1710. 2017. View Article : Google Scholar : PubMed/NCBI